Gram Research analysis of a 2026 mouse study found that a yogurt-derived probiotic, Lactiplantibacillus plantarum F1m, reduced colitis symptoms by raising gut levels of azelaic acid, a molecule that activates the PPARγ pathway. The findings come from animal research, so they cannot yet be applied to people.
A new study reviewed by Gram Research analysis looked at whether a bacterium found in yak yogurt could help with ulcerative colitis, a long-term condition that causes inflammation in the large intestine. Working with mice that had colitis induced in a lab, researchers found that the bacterium, Lactiplantibacillus plantarum F1m, eased symptoms, helped repair the gut lining, and shifted the balance of gut microbes. The bacterium also increased levels of a molecule called azelaic acid, which gut microbes help produce. Azelaic acid appeared to activate a cell receptor called PPARγ that helps calm inflammation, and giving it directly also reduced colitis in the mice. These results are promising, but they come from animal research and do not yet show whether the same approach works in people.
Key Statistics
A 2026 mouse study published in the Journal of Agricultural and Food Chemistry found that a probiotic bacterium isolated from yak yogurt, Lactiplantibacillus plantarum F1m, increased levels of azelaic acid in mice with colitis.
The same 2026 study identified azelaic acid as a gut microbe-derived molecule that activates the PPARγ receptor, and found that giving azelaic acid directly reduced colitis in mice in a PPARγ-dependent manner.
The Quick Take
- What they studied: Researchers asked whether a probiotic bacterium from yak yogurt could reduce inflammation in the colon, and how it might work.
- Who participated: The study used laboratory mice with colitis triggered by a chemical called dextran sulfate sodium. The exact number of mice was not specified in the summary available for this review.
- Key finding: The probiotic eased colitis symptoms in mice and raised levels of azelaic acid, a molecule made with help from gut microbes. Giving azelaic acid directly also reduced colitis, suggesting it plays a central role in the effect.
- What it means for you: This is early laboratory evidence in animals, not proof that yogurt or probiotic supplements can treat colitis in people. Anyone with ulcerative colitis should keep following their doctor’s treatment plan and talk with a doctor before changing their diet or supplements.
The Research Details
The researchers first isolated a bacterium called Lactiplantibacillus plantarum F1m from yak yogurt. They then gave it to mice that had colitis caused by a chemical added to their drinking water. This allowed the team to compare mice that received the bacterium with those that did not.
To understand how the effect happened, the team examined the mice’s gut microbes, the gut lining, and inflammation-related signals in the body. They also measured the chemicals present in the mice’s bodies, a method called metabolomics, which helped them find azelaic acid as a key molecule.
Finally, the researchers tested whether azelaic acid itself could calm colitis, and checked whether its effect depended on the PPARγ receptor. This step helps show cause and effect, not just a connection between the bacterium and the result.
Using controlled animal experiments lets scientists change one factor at a time, such as giving a bacterium or a single molecule, and watch what happens. This design is useful for uncovering possible mechanisms, which is hard to do in people. However, results in mice do not always carry over to humans, so this step is an important early stage before clinical trials.
The study was published in the Journal of Agricultural and Food Chemistry, a peer-reviewed scientific journal. It tested a proposed mechanism in more than one way, including a direct test of azelaic acid, which strengthens the link between the findings. The summary available for this review does not report the number of mice, so it is harder to judge how precise the results are. Readers should look at the full paper for those details.
What the Results Show
The main result was that the yak yogurt bacterium improved colitis symptoms in mice. Colitis is inflammation of the colon, and the mice treated with the bacterium showed better symptoms and a healthier gut lining than untreated mice with the same condition. A healthier gut lining acts like a sturdier wall that keeps harmful substances from leaking into the body.
The bacterium also changed the community of microbes living in the gut. It increased Bacteroidota, a group of gut bacteria, and reduced Bacillota, another group that had been pushed out of balance by the colitis. It also increased two beneficial genera, Faecalibaculum and Akkermansia, which are often linked to a healthier gut environment.
On a molecular level, the bacterium calmed two inflammation-driving pathways, called NF-κB and ERK/MAPK, while switching on the PPARγ pathway. Metabolomic analysis showed that mice receiving the bacterium had higher levels of azelaic acid, and these levels were linked to certain Bifidobacterium species and a gut archaeon called Methanobrevibacter smithii.
The researchers found that azelaic acid acts as a PPARγ ligand, meaning it binds to and activates this receptor. When they gave azelaic acid directly to mice, it reduced colitis, and this effect depended on PPARγ, supporting the idea that this pathway is central to the benefit.
The study suggests that the bacterium’s benefits may come partly from its ability to reshape gut microbes, not only from the bacterium itself. This matters because it points to a possible route where a probiotic helps the body make its own anti-inflammatory compounds. The link between azelaic acid and specific Bifidobacterium species also hints that certain gut microbes may be useful partners in this process. These are early associations, so they require further testing to confirm cause and effect.
Probiotics have been studied for ulcerative colitis for years, with mixed results, and scientists have often struggled to explain why some strains work and others do not. This study adds a specific chain of events: a probiotic shifts gut microbes, which increases azelaic acid, which activates PPARγ. PPARγ is already a known target for anti-inflammatory drugs in the gut, so this link fits with earlier work. Still, the full chain has been shown in mice, and it is not yet known whether it holds in people.
The most important limitation is that this was an animal study. Mice are useful models for early research, but their immune systems and gut environments differ from those of humans. The colitis was also induced by a chemical, which may not perfectly match ulcerative colitis in people, a condition with complex and varied causes. The summary available for this review does not report the number of mice, the duration of treatment, or long-term outcomes, so readers cannot yet judge how durable the effects might be. Finally, the study shows links and mechanisms, but human clinical trials would be needed before any treatment recommendation could be made.
The Bottom Line
Based on this single animal study, the evidence is promising but early. Confidence that the bacterium or azelaic acid would help people with ulcerative colitis is currently low, because no human data are presented here. Researchers would need controlled trials in people before any clinical recommendation. Anyone interested in gut health should focus on established steps, such as following their doctor’s advice and eating a varied, fiber-rich diet, rather than relying on a single probiotic strain.
People with ulcerative colitis or other inflammatory bowel conditions, their doctors, and researchers working on probiotics or gut health may find this study especially relevant. People taking prescribed medications should not stop or change them based on this research. Healthy adults who are curious about probiotics should also understand that results from a specific strain in mice do not automatically apply to store-bought yogurt or supplements.
Translating findings from mouse studies into approved treatments usually takes many years. Early human trials would typically come first, followed by larger studies to confirm safety and effectiveness. Anyone hoping for practical changes should expect a long research process before this approach could be used in clinical care.
Frequently Asked Questions
Can yogurt bacteria help treat ulcerative colitis?
A 2026 mouse study found that a yak yogurt bacterium, Lactiplantibacillus plantarum F1m, reduced colitis symptoms in mice. Research in people has not yet been conducted, so the findings cannot show whether it helps humans. Anyone with ulcerative colitis should follow their doctor’s treatment plan.
What is azelaic acid and how does it affect the gut?
Azelaic acid is a molecule that gut microbes help produce. In a 2026 mouse study, it activated the PPARγ receptor, which helps calm inflammation, and giving it directly reduced colitis in mice. Its role in human digestion has not yet been confirmed.
Does this study prove probiotics work for colitis in people?
No single animal study proves that. The 2026 research tested a specific bacterium in mice with chemically induced colitis, and the summary does not report human outcomes. Human clinical trials would be needed before probiotics could be recommended for ulcerative colitis treatment.
Should I stop my colitis medication and start eating more yogurt?
No. Stopping prescribed colitis medication can cause serious flare-ups. This mouse study does not show that yogurt or probiotics can replace treatment. Talk with your doctor before changing your medications, diet, or supplements.
Want to Apply This Research?
- Log daily bowel symptoms, such as frequency, urgency, and blood in stool, on a simple 1 to 5 scale, and note any probiotic or fermented food you consume. Reviewing these logs over several weeks can help you and your doctor spot patterns, but it cannot show whether a specific food caused a change.
- Consider adding fiber-rich foods such as oats, beans, vegetables, and fruit to your meals, and keep a record of how your gut feels. If you want to try fermented foods such as plain yogurt, discuss it with your healthcare provider first, especially if you have an existing gut condition.
- Track symptoms, diet, and any new supplements monthly, and schedule regular check-ins with your healthcare team. Share the app’s summary reports at medical appointments, and update your log whenever your treatment plan changes, so trends are easier to interpret over time.
This article summarizes a laboratory study conducted in mice and is not medical advice. The findings have not been tested in humans, and they should not be used to diagnose, treat, or prevent any condition. Anyone with ulcerative colitis or another digestive condition should consult a qualified healthcare provider before making changes to medications, diet, or supplements.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.